Further network pharmacology analysis (PPI and KEGG enrichment analysis) showed that key targets such as AKT, IL1, TNF, NRF2, and IL-6, as well as antioxidant pathways, play important roles in the pathological process of EMs. This evidence concerns the gene TNF and eosinophilia-myalgia syndrome.